Compare XRX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRX | SOPH |
|---|---|---|
| Founded | 1906 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.3M | 462.3M |
| IPO Year | 2019 | 2021 |
| Metric | XRX | SOPH |
|---|---|---|
| Price | $3.03 | $7.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $3.82 | ★ $9.75 |
| AVG Volume (30 Days) | ★ 2.3M | 662.7K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | ★ 23.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $117,000,000.00 | N/A |
| Revenue This Year | $8.24 | $23.24 |
| Revenue Next Year | N/A | $24.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $3.75 |
| 52 Week High | $3.78 | $8.98 |
| Indicator | XRX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 36.65 |
| Support Level | $2.97 | $4.58 |
| Resistance Level | $3.17 | $8.80 |
| Average True Range (ATR) | 0.17 | 0.50 |
| MACD | -0.06 | -0.14 |
| Stochastic Oscillator | 21.98 | 2.12 |
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.